Zepp Health Corporation ZEPP
NYSE
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -19.00% | -- | -- | -51.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -19.00% | -- | -- | -51.00% |
| Cost of Revenue | -- | -21.30% | -- | -- | -60.43% |
| Gross Profit | -- | -14.85% | -- | -- | -18.56% |
| SG&A Expenses | -- | 14.45% | -- | -- | -13.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -9.03% | -- | -- | -47.21% |
| Operating Income | -- | -95.77% | -- | -- | 8.36% |
| Income Before Tax | -- | -172.46% | -- | -- | 19.16% |
| Income Tax Expenses | -- | 370.31% | -- | -- | 152.07% |
| Earnings from Continuing Operations | -- | -194.69% | -- | -- | 0.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -38.89% | -- | -- | -67.65% |
| Net Income | -- | -195.17% | -- | -- | 0.73% |
| EBIT | -- | -95.77% | -- | -- | 8.36% |
| EBITDA | -- | -155.63% | -- | -- | 8.78% |
| EPS Basic | -- | -197.97% | -- | -- | 6.14% |
| Normalized Basic EPS | -- | -0.56% | -- | -- | 26.24% |
| EPS Diluted | -- | -195.71% | -- | -- | 3.57% |
| Normalized Diluted EPS | -- | -0.33% | -- | -- | 26.29% |
| Average Basic Shares Outstanding | -- | 2.09% | -- | -- | 4.41% |
| Average Diluted Shares Outstanding | -- | 0.78% | -- | -- | 3.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |